Advanced BioMedical Technologies Inc - ABMT stock
OTC Symbol: ABMT | OTC Tier: Pink Limited
About ABMT[edit]
Advanced BioMedical Technologies, Inc. (OTC: ABMT) is a US-based medical device company that specializes in the design, development, and commercialization of innovative surgical devices and technologies. The company is based in Massachusetts and was founded in 2015. Overall, ABT is a dynamic and innovative company that is making significant contributions to the field of orthopedic and spine surgery. The company's products have the potential to improve patient outcomes and reduce healthcare costs, and it is well-positioned to continue growing and expanding its product portfolio in the years to come.[1]
Products[edit]
ABT has a strong commitment to innovation and is constantly working to improve its existing products and develop new technologies. The company works closely with leading surgeons and medical professionals to ensure that its products meet the highest standards of safety and efficacy.[2]
Surgical[edit]
ABT is focused on developing products that address unmet needs in the surgical market, with a particular emphasis on orthopedic and spine procedures. The company's flagship product is the LaFleur Screw System, which is a unique orthopedic screw system that offers improved strength and stability compared to traditional screws. The LaFleur Screw System is designed to be used in a variety of surgical applications, including spinal fusion and fracture fixation.[2]
In addition to the LaFleur Screw System, ABT is also developing a range of other surgical devices and technologies, including implants for joint reconstruction and soft tissue repair.[2]
Polymer Fixation Screws[edit]
In 2019 they received approval from the Chinese CFDA for polymer fixation screws.[3]
Patents[edit]
In 2018 the Advanced Biomedical was granted a patent titled "Bone Fracture Plate Made of High Polymer Materials”.[4]
Sales Campaign
In November of that year they announced the launch of a sales campaign between their subsidiary Shenzhen Changhua Biomedical Engineering Co. Ltd. and medical device sales company Guangzhou Ding Hua Biomedical Technology Ltd.[5]
Financial Performance[edit]
Total revenue for the year ending 10/31/2020 was $123,587, net income was -$-672,000, and earnings per share was -$0.01.[6]
- ↑ abtlafleur.com. Home. Retrieved on 4/9/2023.
- ↑ 2.0 2.1 2.2 abtlafluer.com. Technology. Retrieved on 4/9/2023.
- ↑ GlobeNewswire. Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws. April 19, 2018.
- ↑ GlobeNewswire. Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology. January 30, 2018.
- ↑ GlobeNewswire. Advanced Biomedical Technologies Inc. Launches Sales Campaign. November 06, 2019.
- ↑ Yahoo Finance - ABMT Financials
